-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Terns Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q2 2024.
- Terns Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $61K, a 15.3% decline year-over-year.
- Terns Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $265K, a 42.8% decline year-over-year.
- Terns Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $239K, a 33.2% decline from 2022.
- Terns Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $358K, a 29.5% decline from 2021.
- Terns Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $508K, a 37.5% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)